Prediction of no reflow phenomenon in patients with acute myocardial infarction  undergoing coronary intervention by CHA2DS2VASc score

doi:10.3969/j.issn.1004-583X.2020.09.004

Abstract

Abstract: Objective To verify the clinical predictive value of CHA2DS2VASc score in the absence of reflow in STsegment elevation myocardial infarction (STEMI) patients after direct percutaneous coronary intervention (PCI). Methods 300 STEMI patients admitted to our hospital for primary PCI were divided into two groups: 27 patients without reflow as the first group, and the remaining 273 patients as the control group. CHA2DS2VASc risk score was calculated for each patient.Results There was statistically significant difference in multivariate analysis between CHA2DS2VASc score and nonreflow correlation (P<0.05).The components of CHA2DS2VASc score showed significant differences in the prediction ability of nonreflow(P<0.05). ConclusionIn STEMI patients treated with primary PCI, higher CHA2DS2VASc score was associated with the risk of no reflow and inhospital mortality.

Key words: myocardial infarction, angioplasty, transluminal, , percutaneous coronary, electrocardiography

Sun Wei. Prediction of no reflow phenomenon in patients with acute myocardial infarction undergoing coronary intervention by CHA2DS2VASc score[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2020.09.004.

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2020.09.004

https://lchc.magtechjournal.com/EN/Y2020/V35/I9/792

[1]	Zhang Lei, Li Xin, Guo Zhenfeng. Efficacy and safety of intracoronary injection of teneplase versus tirofiban on the treatment of acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2024, 39(7): 598-602.
[2]	Li Yanan, Zhang Hongyu. Clinical study of the efficacy of intracoronary injections of low-dose prourokinase through the tail of the balloon on acute ST-segment elevation myocardial infarction patients undergoing percuteneous coronary intervention [J]. Clinical Focus, 2024, 39(6): 518-523.
[3]	Zhang Canna, Xiang Lu, Luo Yaxiong. Electrocardiographic findings of the spiked helmet sign: A case report and literature review [J]. Clinical Focus, 2023, 38(5): 444-447.
[4]	Yan Haiyan, Ding Yankui, JiaHongjing , WangJiyuan , Zhang Xuewei, Hu Yinjie, Chu Junjie, Hu Hongyan, Guo Gaofeng. Correlation of pre-hospital heparinization combined with one pack of drugs and revascularization in patients with acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2023, 38(3): 232-236.
[5]	Li Nana, Jiang Shan. Predictive values of serum homocysteine, cystatin C and high sensitive C-reactive protein levels on heart failure after percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction [J]. Clinical Focus, 2023, 38(2): 121-125.
[6]	Wang Jiaqi, Wang Wenjing, Liu Litian, Zhang Feifei, Dang Yi, Qi Xiaoyong. Acute myocardial infarction caused by spontaneous coronary artery dissection in a young woman: A case report and literature review [J]. Clinical Focus, 2023, 38(2): 162-165.
[7]	Wang Jiaqi, Gao Man, Zhang Feifei, Li Yingxiao, Dang Yi, Qi Xiaoyong. Predicting value of neutrophil to lymphocyte ratio combined with GRACE score on in-hospital major adverse cardiovascular events of postoperative PCI in acute STEMI patients [J]. Clinical Focus, 2022, 37(5): 412-417.
[8]	Wang Yajie, Lin Wenhua, Jing Rui, Liu Jingjing, Lu Yujie. The relationship between serum homocysteine levels and SYNTAX score in patients with non-ST-segment elevation myocardial infarction [J]. Clinical Focus, 2022, 37(4): 325-328.
[9]	Deng Kaibin, Han Liang, Niu Shaoqian, Wang Haiyan, Wang Yanbo, Fu Yang, Wang Qing, Zhan Yang, Fu Xianghua. Effect of optimized treatment approach on acute STEMI patients under the situation of prevention and control of COVID-19 [J]. Clinical Focus, 2021, 36(7): 595-599.
[10]	Shi Jun, Liu Xinbing, Bai Yanyan, Yue Dandan, Wang Xiaoqing, Liu Tianhua, Feng Liuliu. Influencing factors of myocardial microcirculation perfusion disorder after percutaneous coronary intervention in acute myocardial infarction and relationship with lactic acid [J]. Clinical Focus, 2021, 36(5): 402-407.
[11]	Zhang Xiaole, Cai Zhaoxu, Zhang Heqiong, Wang Yangyang, Lu Shaoyun, Yang Chunwan. Clinical application of thromboelastogram in patients with primary acute myocardial infarction [J]. Clinical Focus, 2021, 36(2): 125-128.
[12]	Wang Yajie, Lin Wenhua, Jing Rui, Liu Jingjing, Lu Yujie. Relationship between aVR lead ST-segment elevation with SYNTAX score in patients with acute non-ST-segment elevation myocardial infarction [J]. Clinical Focus, 2021, 36(10): 933-936.
[13]	Zhou Jing, Dai Yunlang. Clinical characteristics and prognosis of patients with isolated left main stenosis in coronary intervention [J]. Clinical Focus, 2021, 36(1): 12-15.
[14]	Su Jiangbo, Yang Lixia, Liu Junqi. Effects of pharmaceutical intervention on medication adherence and prognosis of discharged patients with myocardial infarction [J]. Clinical Focus, 2021, 36(1): 21-24.
[15]	Li Lei, Li Huixiao. Comparative study of urokinaseselective intracoronary thrombolysis combined with interventional therapy and direct percutaneous coronary intervention in acute ST segment elevation myocardial infarction [J]. Clinical Focus, 2020, 35(8): 693-696.

Prediction of no reflow phenomenon in patients with acute myocardial infarction undergoing coronary intervention by CHA2DS2VASc score

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments